X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-03-17 | TMCI | Scanlan Sean F. | Chief Innovation Officer | S - Sale+OE | $7.97 | -50,000 | 364,081 | -12% | -$398,460 | |||||
2025-03-04 | TMCI | Treace John T. | CEO, 10% | P - Purchase | $8.73 | +60,000 | 12,120,319 | 0% | +$524,064 | ||||||
2024-09-16 | TMCI | Treace John T. | CEO, 10% | P - Purchase | $5.31 | +50,000 | 11,847,224 | 0% | +$265,630 | ||||||
2024-08-15 | TMCI | Treace James T | Dir | P - Purchase | $5.96 | +84,000 | 1,779,624 | +5% | +$501,035 | ||||||
2024-08-14 | TMCI | Treace John T. | CEO, 10% | P - Purchase | $6.00 | +85,000 | 11,797,224 | +1% | +$510,315 | ||||||
2024-06-11 | TMCI | Treace John T. | CEO, 10% | P - Purchase | $5.88 | +45,000 | 11,712,224 | 0% | +$264,600 | ||||||
2024-05-31 | TMCI | Treace James T | Dir | P - Purchase | $6.05 | +25,000 | 1,695,624 | +1% | +$151,328 | ||||||
2024-05-29 | TMCI | Treace James T | Dir | P - Purchase | $5.20 | +25,000 | 1,670,624 | +2% | +$130,063 | ||||||
2024-05-28 | TMCI | Treace James T | Dir | P - Purchase | $5.07 | +50,000 | 1,645,624 | +3% | +$253,475 | ||||||
2024-05-22 | TMCI | Mott Richard W | Dir | P - Purchase | $4.99 | +12,100 | 1,054,944 | +1% | +$60,425 | ||||||
2024-05-17 | TMCI | Treace John T. | CEO, 10% | P - Purchase | $5.56 | +100,000 | 11,667,224 | +1% | +$556,170 | ||||||
2024-05-14 | TMCI | Kiernan Jane E | Dir | P - Purchase | $5.17 | +19,356 | 24,941 | +347% | +$100,001 | ||||||
2024-05-14 | TMCI | Treace John T. | CEO, 10% | P - Purchase | $5.12 | +150,000 | 11,567,224 | +1% | +$767,805 | ||||||
2024-05-10 | TMCI | Jain Deepti | Dir | P - Purchase | $4.50 | +25,000 | 31,235 | +401% | +$112,568 | ||||||
| M | 2024-05-10 | TMCI | Mott Richard W | Dir | P - Purchase | $4.51 | +120,000 | 1,027,753 | +13% | +$540,939 | |||||
| M | 2024-05-10 | TMCI | Treace James T | Dir | P - Purchase | $4.54 | +228,000 | 1,595,624 | +17% | +$1,034,004 | |||||
2024-05-10 | TMCI | Bakewell John K | Dir | P - Purchase | $4.57 | +130,000 | 477,348 | +37% | +$594,620 | ||||||
| M | 2024-05-10 | TMCI | Treace John T. | CEO, 10% | P - Purchase | $4.57 | +300,000 | 11,417,224 | +3% | +$1,370,370 | |||||
2022-11-15 | TMCI | Treace James T | Dir | S - Sale | $20.29 | -50,000 | 1,592,624 | -3% | -$1,014,692 | ||||||
| M | 2023-06-02 | TMCI | Bays F Barry | Former Director | S - Sale | $26.51 | -1,090,821 | 0 | -100% | -$28,917,665 | |||||
| D | 2023-05-16 | TMCI | Scanlan Sean F. | Chief Innovation Officer | S - Sale+OE | $25.44 | -25,000 | 32,395 | -44% | -$635,978 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |